At the news
? NEUTRALIMPACT 2/10 CLUSTER filed May 6, 2026 at 20:00 ET
Three insiders at LeMaitre Vascular sold a total of $1.31M in open-market sales within a week of the company reporting strong Q1 2026 earnings (EPS +42% YoY, raised guidance). The sales follow a 69% rally in LMAT over the past year and represent routine portfolio diversification by directors and an operations executive, the total is only ~0.05% of the $2.5B market cap, well below the materiality threshold.
- Three insiders sold a combined $1.31M in open-market sales over 2 days (May 7-8, 2026)
- Total sales represent ~0.05% of LMAT's $2.5B market cap, trivial
- Sales occurred 2-3 days after Q1 2026 earnings beat (EPS $0.68 vs $0.66 consensus) and raised guidance
- Director Ross sold $560K after exercising options at $48.60; Director Jasinski sold $434K after exercising options at $47.19
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access